![Faraj Nakhleh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Faraj Nakhleh
Chairman at EMERGIA INC.
Faraj Nakhleh active positions
Companies | Position | Start | End |
---|---|---|---|
EMERGIA INC. | Chairman | 16/04/2024 | - |
Director/Board Member | 01/06/2022 | 16/04/2024 | |
Independent Dir/Board Member | 01/06/2022 | 16/04/2024 | |
Trak Concepts, Inc. | Chief Executive Officer | 09/10/2009 | - |
President | 09/10/2009 | - |
Career history of Faraj Nakhleh
Former positions of Faraj Nakhleh
Companies | Position | Start | End |
---|---|---|---|
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Director/Board Member | 30/06/2010 | 08/04/2011 |
Raymond Chabot Grant Thornton LLP
![]() Raymond Chabot Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Raymond Chabot Grant Thornton LLP engages in the provision of tax, recovery and organization, management consulting, financial advisory, digital and technology, assurance and human resource consulting services. It serves the tourism, leisure and culture, natural resources, mining and forestry, manufacturing, and retail and distribution industry. The company was founded in 1948 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 09/10/2009 | - |
NTI Newmerical, Inc.
![]() NTI Newmerical, Inc. Packaged SoftwareTechnology Services NTI Newmerical, Inc. develops advanced CFD multi-disciplinary simulation software for the aeronautics, automotive, marine and power and process industries. It develops and provides in-flight icing simulation software and associated design, testing and certification services to aerospace companies desirous to apply safety standards that meet and exceed regulations. It was founded by Wagdi G. Habashi is headquartered in Montreal, Canada. | Director/Board Member | 26/10/2001 | - |
Training of Faraj Nakhleh
Robert College | Undergraduate Degree |
McGill University | Graduate Degree |
Statistics
International
Canada | 6 |
United States | 2 |
Turkey | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 1 |
President | 1 |
Sectoral
Consumer Services | 3 |
Technology Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
EMERGIA INC. | Finance |
Private companies | 4 |
---|---|
NTI Newmerical, Inc.
![]() NTI Newmerical, Inc. Packaged SoftwareTechnology Services NTI Newmerical, Inc. develops advanced CFD multi-disciplinary simulation software for the aeronautics, automotive, marine and power and process industries. It develops and provides in-flight icing simulation software and associated design, testing and certification services to aerospace companies desirous to apply safety standards that meet and exceed regulations. It was founded by Wagdi G. Habashi is headquartered in Montreal, Canada. | Technology Services |
Trak Concepts, Inc. | |
Raymond Chabot Grant Thornton LLP
![]() Raymond Chabot Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Raymond Chabot Grant Thornton LLP engages in the provision of tax, recovery and organization, management consulting, financial advisory, digital and technology, assurance and human resource consulting services. It serves the tourism, leisure and culture, natural resources, mining and forestry, manufacturing, and retail and distribution industry. The company was founded in 1948 and is headquartered in Montreal, Canada. | Commercial Services |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
- Stock Market
- Insiders
- Faraj Nakhleh
- Experience